Leucettinib-21, a DYRK1A inhibitor drug candidate aiming at the correction of cognitive disorders in people with Down syndrome or Alzheimer’s disease (unset title)

unset title > Event_plural > Leucettinib-21, a DYRK1A inhibitor drug candidate aiming at the correction of co... > status change

search

actions - event

state: published

cancelpublished Leucettinib-21, a DYRK1A inhibitor drug candidate aiming at the correction of co...

status will change from published to submitted

Event #730798 - latest update on 2023/09/27, created on 2023/09/27